Cover Image

The Relation between serum uric acid & HbA1c in geriatric patients of Type 2 Diabetes in Amravati, Maharashtra, India.

Jagtap M. W., Rohankar P. H., Shital Ashokrao Kale*

Abstract


Type 2 Diabetes mellitus (DM) is a heterogeneous disease which is characterized by variable degrees of insulin resistance or/and impaired insulin secretion as well as its deficiency (absolute/relative). The study was carried out to determine the relationship between serum concentration of uric acid and HbA1c among the geriatric group with type 2 diabetes mellitus in diabetic camps carried out at Amravati. We performed a cross sectional study on 30 patients of both genders of geriatric group, and a control group of 30 age and sex matched normal healthy individuals. Serum uric acid was tested by Uricase/PAP method [7, 15] and HbA1c by NycoCard READER II (color reflectometry) [6]. We observed the positive correlation between uric acid and HbA1c, as 0.080 which was found to be significant as 2.50 between the uric acid and HbA1c in geriatric patients of type 2 Diabetes. In healthy controls, we observed the positive correlation between uric acid and HbA1c as 0.074 which was not significant.


Keywords


Uric acid; HbA1c; Type2 diabetes; Diabetes mellitus.

Full Text:

PDF

References


Amandeep Kaur, Sahiba Kukreja, Naresh Malhotra, and Neha. “Serum Adenosine Deaminase activity and its correlation with glycated haemoglobin levels in patients of Type 2 Diabetes mellitus”. Internal Medicine section. vol.3926, 2012: 1567-1570.Print.

D. Nathan. “Effect of Intensive Therapy on the Development and Progression of Diabetic Nephropathy in the Diabetes control and complications.” Trial, Kidney International. vol.47, 1999: 1703-1720.Print.

Dehghan Abbas, Mandy van Hoek, Eric J.G., Si J brands, Albert Hofman, Jacqueline C.M. witteman. “High serum uric acid as a Novel Risk factor for Type 2 Diabetes.” Diabetes Care, Vol. 31, 2008: 353-360. Print.

Diabetes in control. “Risk of Developing Diabetes Increases with Rising Serum Uric acid levels”. Diabetes care, vol.31, 2008:361-362.Print.

Diabetes Co. UK. “Guide to HbA1c”. The global diabetes. Comm. 2016.

European Reference Laboratory for Glycohaemoglobin, Manufacture check-up certification of NycoCard HbA1c. 1998.

Fossati, p. Prencipe, L (1980) “Clin.Chem”.26:227.

Hidayat Muhammad Fahmi, Santi Syafril, Dharma Lindate. “To Elevated uric acid level decreases glycated haemoglobin in type 2 diabetes mellitus.” Directory of pien access journals, Vol. 33, 2014.

John E. Morley: “The Elderly Type 2 Diabetic patient: special considerations”. Diabetic Medicine, vol.15, 1998: s41-s46.Print.

Kamran M.A. Aziz. “Effect of serum Acid in Augmentation of insulin secretion and Improvement of HbAlc in Diabetic patients”: [proposed statistical Regression models for uric acid, HbA1c and Insulin] 2013.

Kim Kyung Soo, seok won park. “Exercise and Type 2 Diabetes.” Korean Diabetes. Vol .13 (2), 2012:61-68. Print.

M., Wei, Gaskill, S.P. Haffner S.M., Stern M.P. “Effect of Diabetes and Level of Glycaemia on All cause and Cardiovascular Mortality.” Diabetes Care, vol.21, 1998: 1167-72. Print.

R. Turner: “Effect of Intensive Blood Glucose Control with Metformin on Complications in overweight patients with Type 2 Diabetes.” Lancet, vol.352, 1998: 854-65. Print

Targher G, chonchol M, Pichiri I, Zoppini G. “Risk of Cardiovascular disease and chronic Kidney disease in diabetic”. Just a coincidence J E endocrinol Invest 34 [7]; 2011; Pp544-51.

Trinder, P., (1969): Ann.Biochem.6:24.

“U.S. Department of Health and Human Services Centers for Disease Control and Prevention National Diabetes Fact Sheet”. General Information and National Estimates on Diabetes in the United States, 2007.

U.S. National library of Medicine: Uric acid urine test, Medline plus.

Van den Oever IA, Raterman HG, Nurmohamed MT, Simsek S. “Endothelial dysfunction, inflammation and apoptosis in diabetes mellitus”. Mediators Inflamm. 2010:792393.

World Health Organization: “Global Strategy on Diet”. Physical Activity and Health: Diabetes. Geneva, World Health Organization, 2006.




DOI: http://dx.doi.org/10.21746/ijbio.2016.06.009

Refbacks

  • There are currently no refbacks.




Copyright (c) 2016 International Journal of Bioassays

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

International Journal of Bioassays is a member of the Publishers International Linking Association, Inc. (PILA), CROSSREF and CROSSMARK (USA). Digital Object Identifier (DOI) will be assigned to all its published content.